CC
TNDM icon

Corton Capital’s Tandem Diabetes Care TNDM Stock Holding History

Corton Capital’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,038
Closed -$243K – 402
2025
Q2 		$243K Buy
+13,038
New +$258K 0.28% 147

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
FGP
Freestone Grove Partners San Francisco, California $14.2B AUM 24.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Corton Capital's TNDM Position: Q3 2025 in Review

Corton Capital sold out of Tandem Diabetes Care (TNDM) in Q3 2025, closing a stake of 13,038 shares — an estimated $243K sold.

Corton Capital first reported a position in TNDM in Q2 2025 and held it in 1 quarter. The position peaked at $243K in Q2 2025. 255 funds tracked by Wall St. Rank hold TNDM as of Q3 2025.

  • Corton Capital reported no remaining Tandem Diabetes Care position as of Q3 2025 after selling out during the quarter.
  • Corton Capital sold 13,038 Tandem Diabetes Care shares in Q3 2025, an estimated $243K.
  • Corton Capital first reported a position in Tandem Diabetes Care in Q2 2025 and held it in 1 quarter.
  • Corton Capital's Tandem Diabetes Care position peaked at $243K in Q2 2025.
  • 255 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2025.

Based on Corton Capital's 13F filing for Q3 2025, filed 14 Nov 2025.